Skip to Content

9 3 7159 (Pergolide 0.25 mg)

Pill imprint 9 3 7159 has been identified as Pergolide mesylate 0.25 mg.

Pergolide is used in the treatment of tourette's syndrome; parkinson's disease; hyperprolactinemia and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Pergolide 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pergolide mesylate 0.25 mg 9 3 7159
Discount Card Promo
Pergolide mesylate
9 3 7159
0.25 mg
Elliptical / Oval
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.